DIRS.INFO The most relevant business & tech news

Michael Bloomberg’s organization Bloomberg Philanthropies is announcing a $600 million gift to the endowments of four historically Black medical schools. Xavier University of Louisiana, which is opening a new medical school, will also receive a $5 million grant. The donations will more than double the size of three of the medical schools’ endowments, Bloomberg Philanthropies said. The four historically Black medical schools are still deciding with Bloomberg Philanthropies how the latest gifts to their endowments will be used, said Garnesha Ezediaro, who leads Bloomberg Philanthropies’ Greenwood Initiative. Dr. Yolanda Lawson, president of the National Medical Association, said she felt “relief,” when she heard about the gifts to the four medical schools.

Persons: Michael Bloomberg’s, Bloomberg Philanthropies, ” Bloomberg, Charles Drew, Garnesha Ezediaro, Ezediaro, ” Ezediaro, Valerie Montgomery Rice, we’ve, ”, Ronda Stryker, William Johnston, Denise Smith, Spelman, Smith, MacKenzie Scott’s, ” Smith, Yolanda Lawson, Utibe Organizations: Bloomberg, New, New York City, National Medical Association, Associated Press, Howard University College of Medicine, Meharry Medical College, Morehouse School of Medicine, Charles, Charles Drew University of Medicine & Science, Xavier University of Louisiana, Johns Hopkins University, Greenwood Initiative, Democratic, United Negro College Fund, Spelman College, Greenleaf Trust, The Century Foundation, David Geffen School of Medicine, UCLA, NBC Locations: New York, Tulsa , Oklahoma, Atlanta, Ronda

☆ Bloomberg gives $600 million to 4 Black medical schools’ endowments
▼ + stars: | 2024-08-06 | by ( Associated Press | ) edition.cnn.com time to read: +6 min

NEW YORK AP —Michael Bloomberg’s organization Bloomberg Philanthropies is announcing a $600 million gift to the endowments of four historically Black medical schools. Xavier University of Louisiana, which is opening a new medical school, will also receive a $5 million grant. The donations will more than double the size of three of the medical schools’ endowments, Bloomberg Philanthropies said. The four historically Black medical schools are still deciding with Bloomberg Philanthropies how the latest gifts to their endowments will be used, said Garnesha Ezediaro, who leads Bloomberg Philanthropies’ Greenwood Initiative. Dr. Yolanda Lawson, president of the National Medical Association, said she felt “relief,” when she heard about the gifts to the four medical schools.

Persons: Michael Bloomberg’s, Bloomberg Philanthropies, ” Bloomberg, Charles Drew, Garnesha Ezediaro, Ezediaro, ” Ezediaro, Valerie Montgomery Rice, we’ve, ”, Ronda Stryker, William Johnston, Denise Smith, Spelman, Smith, MacKenzie Scott’s, ” Smith, Yolanda Lawson, Utibe Organizations: Bloomberg, New, New York City, National Medical Association, Associated Press, Howard University College of Medicine, Meharry Medical College, Morehouse School of Medicine, Charles, Charles Drew University of Medicine & Science, Xavier University of Louisiana, Johns Hopkins University, Greenwood Initiative, Democratic, United Negro College Fund, Spelman College, Greenleaf Trust, The Century Foundation, David Geffen School of Medicine, UCLA Locations: New York, Tulsa , Oklahoma, Atlanta, Ronda

While both numbers were more than any other nation, it was a slight step back by supremely high U.S. standards. No American man had won an individual gold this meet until Finke set his world mark. “The whole ‘the men’s team hasn’t won an individual gold medal’ [narrative] was in the back of my mind,” he told reporters. The U.S. team of Ryan Murphy, Nic Fink, Caeleb Dressel and Hunter Armstrong took silver and France the bronze. “The wealth is just getting spread around, we’re not getting any worse,” said Dressel, who took home two golds and a silver from these Games.

Persons: Bobby Finke, Finke, hasn’t, ”, “, Regan Smith, Lilly King, Gretchen Walsh, Torri Huske, Ryan Murphy, Nic Fink, Caeleb Dressel, Hunter Armstrong, Dressel, we’re Organizations: Paris La Défense, U.S Locations: NANTERRE, France, U.S, Tokyo, Rio, London, Beijing, Athens, Sydney, Florida, Moscow, United States, China, Australia, Italy

☆ Earnings playbook: Disney and this industrial giant are among companies slated to report this week
▼ + stars: | 2024-08-04 | by ( Fred Imbert | ) www.cnbc.com time to read: +4 min

More than 70 S & P 500 names are slated to report this week, including Disney and Caterpillar . Tuesday Uber Technologies is set to report earnings before the bell. This quarter: The ride-hailing giant is expected to report a 70% year-over-year increase in earnings, LSEG data shows. What history shows: Uber has beaten earnings expectations in six of the last seven quarters, according to data from Bespoke Investment Group. Wednesday Walt Disney is set to report earnings before the open.

Persons: Eli Lilly, Benjamin Black, Uber, Walt Disney, Wells, Steven Cahall, LLY, Eli Lilly's Organizations: Disney, Caterpillar . Pharmaceutical, behemoth, CNBC, Technologies, Investors, Autonomous Vehicle, Deutsche Bank, Investment, Caterpillar, JPMorgan Locations: California

☆ Here are 4 things we're watching closely in the stock market this week
▼ + stars: | 2024-08-04 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. Until then, bad economic news was good news for the stock market, because it meant the Federal Reserve would start cutting interest rates sooner. On Thursday, a drop in U.S. manufacturing activity for July and a jump in initial jobless claims dragged down the market. Next week is light on economic data, so expect earnings reports and CEO commentaries to drive the market action. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stocks, Dow Jones, Jim Cramer, would've, Eli Lilly, Mounjaro, Berkshire Hathaway, Krystal, Tyson, BAX, Owens, Walt, Oscar Health, CRON, Krispy, Papa, Jim Cramer's, Jim Organizations: Nasdaq, Dow, Reserve, Broadcom, Devices, Palo Alto, PMI, Wynn Resorts, Investors, Wynn, Wynn Palace, U.S . Disney, Management, and Drug Administration, Carlyle Group, Krystal Biotech, Tyson Foods, TSN, Alpha Metallurgical Resources, BioCryst Pharmaceuticals, Axsome Therapeutics, Technologies, Clover Health, Realty Income Corp, Avis Budget Group, CSX Corp, CSX, Simon Property Group, Sterling Construction Company, Teradata Corp, Yum China Holdings, ZoomInfo Technologies, Holdings, Caterpillar, Baxter International, Vulcan Materials Company, Allegheny Technologies Incorporated, Constellation Energy Group, Marathon Petroleum Corp, Owens Corning Inc, Duke Energy Corp, GXO Logistics, Brands, Builders, Wynn Resorts Ltd, WYNN, Rivian Automotive, Devon Energy Corp, GigaCloud Technology Inc, Lumen Technologies, VF Corp, Walt Disney Co, Novo Nordisk, CVS Health, Aurora Cannabis Inc, Emerson Electric Co, Sony Group Corporation, SONY, Inc, ODP Corporation, Icahn Enterprises, MannKind Corp, ACM Research, Brink's Company, AppLovin Corporation, Digital Turbine, Sarepta Therapeutics, Occidental Petroleum Corp, Bros, SolarEdge Technologies, Aspen, Coeur D'Alene Mines Corp, Co, Vistra Energy, Cheniere Energy, Cronos, Himax Technologies, Properties Trust, Papa John's, Paramount Global, Trade, Lab, B2Gold Corp, Honest Company, Gilead Sciences, Growth, Nikola Corporation, Embraer, New Fortress Energy, Construction, Jim Cramer's Charitable, CNBC, Disney, Pixar Locations: Palo, Macau, Las Vegas, Boston, Vegas, Wynn Macau, China, Novo, Coeur, Gilead

☆ Here are JPMorgan's top stock picks for August
▼ + stars: | 2024-08-03 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Some stocks have been added and others on this month's list. EQT Corp. has been added, while Arista Networks and Coherent Corp. – two names on last month's list – have been removed. Here are some of JPMorgan's top picks for August: EQT was named as part of the bank's value strategy. Of consumer stocks, McDonald's is also viewed as a value play, with shares of the fast-food chain down 7% this year. For growth stocks, Amazon made the cut.

Persons: EQT, McDonald's, Joe Erlinger, Brian Olsavsky, Donald Trump, Olsavsky, Eli Lilly –, – Organizations: JPMorgan, Dow Jones, EQT Corp, Arista Networks, Amazon, Paris, Microsoft Locations: EQT, McDonald's U.S

☆ Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
▼ + stars: | 2024-08-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. All doses of Eli Lilly's highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug Administration's drug shortage database on Friday. The FDA's update comes one day after Eli Lilly CEO David Ricks told Bloomberg that the shortages of Mounjaro and Zepbound would end "very soon." A spokesperson for Eli Lilly did not immediately respond to CNBC's request for comment on the FDA's update on Friday. Meanwhile, the FDA said some doses of Novo Nordisk's weight loss drug Wegovy have limited supply.

Persons: Eli Lilly’s, Eli Lilly's, Zepbound, Eli Lilly, David Ricks Organizations: U.S . Food, Novo Nordisk, Bloomberg, FDA Locations: New York City, U.S

☆ Wall Street will look for signs of what's next for the market after a rocky start to August
▼ + stars: | 2024-08-02 | by ( Sarah Min | ) www.cnbc.com time to read: +5 min

The S & P 500 ended the week down by 2%. As of Friday, the Nasdaq Composite was more than 10% below its recent high, while the S & P 500 was down by 5.7%. Markets were last pricing in a 71% chance of a half percentage point rate cut in September, up from 22% on Thursday, according to the CME FedWatch Tool . Brands , Fidelity National Information Services , Uber Technologies , Marathon Petroleum , Caterpillar Wednesday Aug. 7 3 p.m. Consumer Credit (June) Earnings: Costco Wholesale , Warner Bros. Discovery , Occidental Petroleum , Ralph Lauren , CVS Health , Hilton Worldwide Holdings , Walt Disney Company Thursday Aug. 8 8:30 a.m.

Persons: Stocks, payrolls, Bill Hornbarger, Benjamin F, Edwards, Russell, Claudia Sahm, selloff, Michael Kantrowitz, Piper Sandler, Kantrowitz, Jan Hatzius, Goldman Sachs, Hatzius, CNBC's, Eli Lilly, Ralph Lauren, Martin Marietta Organizations: Nasdaq, Treasury, Investors, Federal Reserve, Walt Disney Company, Caterpillar, Costco, Micro Computer, PMI, PMI Services, Services PMI, Simon Property Group, Diamondback Energy, Tyson Foods, Devon Energy, Airbnb, Wynn Resorts, TransDigm, Brands, Fidelity National Information Services, Uber Technologies, Marathon Petroleum, Consumer Credit, Costco Wholesale, Warner Bros, Discovery, Occidental Petroleum, CVS Health, Hilton Worldwide Holdings, Gilead Sciences, Akamai Technologies, News Corp, Paramount Global, Expedia, Martin, Martin Marietta Materials Locations: Fortinet, Devon

Jim Cramer said Friday the Fed should have cut at this week's meeting. Those were in place with AMD because Jim Cramer mentioned the stock on CNBC TV over the past 72 hours. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Dow Jones, here's, Eli Lilly, Jim Cramer's, Jim Organizations: CNBC, Dow Jones, Nasdaq, Federal Reserve, Fed, Bond, chipmaker Broadcom, AMD, Palo Alto, Nvidia, Wynn Resorts, Disney, Jim Cramer's Charitable Locations: U.S, DuPont, Dover, Wells

See Where Countersnipers Could Have Stopped the Trump Rally GunmanWhere countersnipers were stationed — and where they were not — has emerged as a point of contention in assessing security failures at the July 13 assassination attempt at a rally for former President Donald J. Trump. Countersniper locations Locations with better views of gunman Water tower Gunman Countersnipers inside building Secure perimeter Trump N Countersniper locations Locations with better views of gunman Water tower Gunman Countersnipers inside building Secure perimeter Trump N Countersniper locations Locations with better views of gunman Water tower Gunman Countersnipers inside building Secure perimeter Trump N Source: Beaver County E.S.U. There were four locations where countersnipers were stationed near the rally, according to Beaver County planning documents. If countersnipers had been positioned atop the water tower, here is what they would have seen. Trump Gunman Countersnipers were inside this building, but the roof offered a better view Trump Gunman Countersnipers were inside this building, but the roof offered a better view Trump Gunman Countersnipers were inside this building, but the roof offered a better view The New York TimesIn the House hearing, Representative Carlos Gimenez of Florida questioned the decision to place countersnipers inside — a position that provided a limited line of sight, unless the countersnipers were sticking their heads out of the windows.

Persons: countersnipers, Donald J, Charles E, Thomas Matthew Crooks, Crooks, Eli Crane, Christopher Paris, Trump, Kimberly Cheatle, Countersnipers, Carlos Gimenez, Ronald L, Rowe Jr, ” Organizations: Trump Rally, Trump, The New York Times, House, Republican, NAVY, Pennsylvania State Police, Secret Service, New York Times Locations: Beaver, Beaver County, Arizona, Florida

☆ Eli Lilly bucks the down market on a case for wider coverage of its weight-loss drug
▼ + stars: | 2024-08-01 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. For the rest of the market, Jim noted "pockets of weakness" in the consumer discretionary and industrials sectors. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Stocks, Jim, Eaton, it's, Eli Lilly, Jim Cramer's Organizations: CNBC, Federal Reserve, Meta, Facebook, Apple, Medicare, Novo Nordisk Locations: Eaton, U.S

☆ Health care bucks sell-off as Eli Lilly soars: Mizuho's Jared Holz on what's next for the group
▼ + stars: | 2024-08-01 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHealth care bucks sell-off as Eli Lilly soars: Mizuho's Jared Holz on what's next for the groupJared Holz, Mizuho, joins 'Fast Money' to talk resilience in the health care sector as the broader market sees a sell-off.

Persons: Eli Lilly, Jared Holz Organizations: Health Locations: Mizuho

☆ Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
▼ + stars: | 2024-08-01 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Eli Lilly 's weight loss drug Zepbound showed benefits in patients with a common type of heart failure and obesity, according to late-stage trial data the company released Thursday. Eli Lilly said it plans to submit the results from the phase three trial to regulators in the U.S. and other agencies starting later this year. Zepbound also significantly improved heart failure symptoms and physical limitations, Eli Lilly said in a release. Eli Lilly will present the data at an upcoming medical meeting and submit it to a peer-reviewed journal.

Persons: Eli Lilly, Zepbound Organizations: Centers for Disease Control, Novo Nordisk, Drug Administration Locations: Brooklyn, New York, U.S

☆ Watch out. These stocks reporting next week are at risk of an earnings blow-up
▼ + stars: | 2024-07-31 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Investors should be wary of those stocks that are due to report next week whose lackluster earnings could send their share prices down. While earnings have been mostly positive this quarter, several stocks could bring bad news and trip up investors. To find these, CNBC Pro screened FactSet for companies reporting next week that have seen their earnings estimates cut by 5% or more in the past three- and six months. The gas pipeline stock has seen analysts' earnings per share estimates cut by 5.3% over the past three months and 18.6% over the past six months. Analysts have slashed their per-share earnings outlook by 44% and 51% in the past three and six months, respectively.

Persons: Walt Disney, Eli Lilly, Williams, Wells, Michael Blum, Blum, FactSet, Rockwell Organizations: Caterpillar, Walt, CNBC Pro, Williams Companies, Mosaic, Rockwell Automation, Rockwell Locations: Wells Fargo, Milwaukee

☆ Here’s Why ‘The Matrix’ Is More Relevant Than Ever
▼ + stars: | 2024-07-31 | by ( Alissa Wilkinson | ) www.nytimes.com time to read: +1 min

Neo, the hero of “The Matrix,” is sure he lives in 1999. But he’s wrong: He lives in the future (2199, to be exact). Neo’s world is a simulation — a fake-out version of the late 20th century, created by 21st-century artificial intelligences to enslave humanity. But the movie’s warnings about A.I. Judged solely on cultural relevance, “The Matrix” might be the most consequential release of 1999.

Persons: it’s, Lilly, Lana Wachowski didn’t

☆ GEHC gives reasons to look beyond temporary China woes and shares reverse higher
▼ + stars: | 2024-07-31 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. Organic revenue growth was 1%. We saw a continued acceleration of Vizamyl doses delivered in the U.S. in the second quarter. This is still a small contributor to sales growth but gives us optimism about its sales potential over the next few years." As a result, we're lowering our total company full-year organic revenue growth guidance."

Persons: Philips, It's, Eli Lilly, GEHC, —, Jay Saccaro, We're, Arduini, Peter Arduini, Jim Cramer's, Jim Cramer, Jim, Pavlo Gonchar Organizations: GE Healthcare, Management, Revenue, LSEG, General Electric, Philips, Siemens, Club, GE Healthcare YTD, GE Healthcare's, Care Solutions, Pharmaceutical Diagnostics, U.S, CNBC, Lightrocket, Getty Locations: China, Eisai, U.S

☆ Some Republicans Embrace Conspiracy Theories on Trump Assassination
▼ + stars: | 2024-07-31 | by ( Annie Karni | ) www.nytimes.com time to read: +1 min

Representative Eli Crane, an Arizona Republican and former Navy SEAL, says he is no conspiracy theorist. But in the weeks since the attempted assassination of Donald J. Trump, he has made the baseless suggestion that the shooting was part of a coordinated campaign by Democrats or shadowy government actors to try to stop the former president from reclaiming the White House. “Not only did they try and bankrupt him, but they tried to put him in prison,” Mr. Crane told Jeff Oravits, a right-wing radio personality in Arizona, last week. “When that didn’t work, they tried to put him in prison for 750 years. And many of us said the next step in this escalation is for them to try and kill him because they can’t — they know they can’t beat him fair and square.”In an appearance on The Glenn Beck Program, Mr. Crane, who traveled to the Pennsylvania rally site where Mr. Trump was shot to conduct his own investigation, said, “I don’t want to be a conspiracy theorist, but at the same time, I don’t want to, you know, rule anything out because I don’t put it past some of the people in our government to do anything necessary to hold on to power.”

Persons: Eli Crane, Donald J, Trump, “, ” Mr, Crane, Jeff Oravits, Glenn Beck, ” Organizations: Arizona Republican, Navy Locations: Arizona, Pennsylvania

☆ Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
▼ + stars: | 2024-07-30 | by ( Meg Tirrell | ) edition.cnn.com time to read: +7 min

“This is the first study that actually looked at a relatively large number of patients for whether there is any neuroprotective effect in Alzheimer’s disease,” Edison said. The trial enrolled predominantly people with mild Alzheimer’s disease, measured by a test known as the Mini-Mental State Examination, a scale that goes up to 30. The GLP-1 drug class also includes Eli Lilly’s Mounjaro and Zepbound, which use the active ingredient tirzepatide, which mimics not just the hormone GLP-1 but another called GIP. But it hasn’t announced any trials of its GLP-1 drugs in Alzheimer’s. GLP-1 drugs can have side effects, though, primarily gastrointestinal problems like nausea and vomiting.

Persons: liraglutide, “, ”, Maria Carrillo, Carrillo, Paul Edison, ” Edison, Edison, Eli Lilly’s Mounjaro, Alzheimer’s Lilly, hasn’t, Lilly, Lars Fruergaard Jorgensen, there’s, Dr, Sanjay Gupta, semaglutide Organizations: CNN, Alzheimer’s Association International Conference, Alzheimer’s Association, Novo Nordisk, Imperial College London, ”, Nordisk, ” Novo Nordisk, CNN Health, University of Oxford, Alzheimer’s Society, Alzheimer’s Locations: United Kingdom, Philadelphia, Alzheimer’s, ” Novo, Danish

☆ Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
▼ + stars: | 2024-07-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

George Frey | ReutersAn older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer's disease by protecting patients' brains, according to data from a mid-stage trial released on Tuesday. Novo Nordisk sells liraglutide as a diabetes and obesity drug under the brand names Victoza and Saxenda, respectively. Alzheimer's disease often causes the brain to shrink as the illness progresses because crucial nerve cells break down and stop working properly. By 2050, the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S. The ongoing EVOKE is examining semaglutide, the active ingredient in Wegovy and Ozempic, in nearly 2,000 Alzheimer's patients.

Persons: George Frey, Eli Lilly, liraglutide, Brian B, Bettencourt, Heather Snyder, Leqembi, Snyder, Dr, Paul Edison, Edison, Bobby Pugh, Bessie Pugh, Karen Pulfer Focht Organizations: Novo Nordisk Pharmaceutical, Reuters, Novo Nordisk, Imperial College London, Alzheimer's Association International Conference, Toronto Star, Getty, Alzheimer's Association, U.S, CNBC, Alzheimer's, Novo Nordisk's, Ave Locations: Provo , Utah, Danish, Philadelphia, Biogen, Novo, Bartlett , Tennessee, U.S

☆ Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
▼ + stars: | 2024-07-29 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +2 min

Swiss pharmaceutical giant Roche said Monday it is accelerating the development of its Wegovy rival weight loss drugs following promising early stage trial data. However, in an FT interview published earlier Monday, CEO Thomas Schinecker indicated that the firm's first obesity drug could come to market "significantly faster than people are expecting," potentially by 2028. Both CT-388 and CT-996 were acquired as part of Roche's purchase of U.S. biotech company Carmot Therapeutics, which completed in January. The promising results could see Roche emerge as a potential rival to obesity drug pioneers Novo Nordisk and Eli Lilly. Schinecker told CNBC last week that he expects the company to eventually offer a suite of obesity medications.

Persons: Roche, Nordisk's Wegovy, Eli Lilly, Thomas Schinecker, Teresa Graham, Roche's, Schinecker Organizations: Nordisk's, CNBC, Roche Pharmaceuticals, Carmot Therapeutics, Novo Nordisk Locations: U.S

☆ Here are JPMorgan's top drug stock picks into earnings
▼ + stars: | 2024-07-29 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

JPMorgan is eyeing a few drug manufacturers ahead of their earnings reports as investors continue to sell out of major technology firms. This backdrop has analyst Chris Schott reviewing JPMorgan's top pharmaceutical and biotechnology stocks, which includes "stories that have clear upside potential to longer-term estimates" like Eli Lilly and Merck. Eli Lilly Pharmaceutical company Eli Lilly made the list. Schott said the firm is somewhat below consensus Wall Street estimates for Eli Lilly heading into second-quarter results on Aug. 8. LLY YTD mountain Eli Lilly stock.

Persons: Johnson, Merck —, Chris Schott, Eli Lilly, Merck, Schott, —, Regeneron Organizations: JPMorgan, Dow Jones, Johnson, Merck, US Major Pharma, Schott, FactSet, Pharmaceuticals Locations: Mounjaro, Novo

☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Live Nation, 3M, Uber, Eli Lilly, Amazon, Coinbase & more
▼ + stars: | 2024-07-29 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Monday's biggest calls on Wall Street: Morgan Stanley reiterates Live Nation as overweight Morgan Stanley said shares of the entertainment concert company are compelling. " Cantor Fitzgerald reiterates Nvidia as overweight Cantor said the stock is still a top pick at the firm. Guggenheim upgrades Akamai to buy from neutral Guggenheim said shares of the cloud computing networking company have more room to run. Bank of America reiterates Apple as buy Bank of America said it's bullish heading into Apple earnings later this week. JPMorgan reiterates Eli Lilly as overweight JPM said the stock is a "core holding" ahead of earnings on August 8.

Persons: Morgan Stanley, Cantor Fitzgerald, Cantor, TD Cowen, AAPL, Wells, Booz Allen Hamilton, it's, Guggenheim, Piper Sandler, Charles Schwab, Piper, Schwab, Olin, Mizuho, Bill Brown's, Myers Squibb, JPMorgan, Eli Lilly, JPM, Evercore, Tesla, Oppenheimer, Raymond James, Davidson, Raymond James downgrades Organizations: NVDA, MU, Apple, Huawei, Booz, Guggenheim, RBC, Deutsche Bank, Northrop, Deutsche, JPMorgan, Uber, Holdings, 3M, " Bank of America, Bank of America, Edge, Barclays downgrades Bristol, Myers Squibb, Barclays, Bristol, Ford, Microsoft, Charter, HSBC Locations: China, underperform

☆ Racked by Pain and Enraptured by a Right-Wing Miracle Cure
▼ + stars: | 2024-07-28 | by ( Eli Saslow | ) www.nytimes.com time to read: +1 min

Michael Chesebro awoke to the same reality as he did each morning, with pain radiating up his spine and into his shoulders before he opened his eyes. He remained still for a moment, summoning the courage to reach from his bed to his night stand. He rolled onto his back, which was fused together with metal after almost 20 years as a paratrooper in the military. He extended his arm, which he had broken several times while wrangling bulls and horses on his ranch outside Cheyenne, Wyo. Finally, his hand found his cellphone, and he logged on to the online universe where he spent most of his days.

Persons: Michael Chesebro, “, ”, Michael, “ I’m, ” Michael, Warren Armour Organizations: Patriot Party, Patriot Party News, Facebook Locations: Cheyenne, Kansas, Texas, Tennessee

☆ These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
▼ + stars: | 2024-07-28 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +6 min

With billions at stake, that's pretty much been a guarantee facing the current market leaders, Eli Lilly and Novo Nordisk , from the start. Their updates are likely to be joined by others in the coming months even as today's incumbents develop their own next-generation weight loss treatments. Other analysts have also grown more optimistic about the future of weight loss treatments. Orforglipron, a once-a-day oral GLP-1 drug that Lilly is working on, had shown a 3% weight loss at 4 weeks. The company is also exploring whether the weight loss treatment could be given only once a month.

Persons: Eli Lilly, drugmakers Roche, Lilly, Denmark's, Trung Huynh, Huynh, Rajesh Kumar, Kumar, Novo, Roche, Roche ADRs, Justin Zelin, Zelin, Viking's, HSBC's Kumar, Novo aren't, —, Nick Wells Organizations: Novo Nordisk, Viking Therapeutics, UBS, HSBC Global Research, Carmot Therapeutics, Food and Drug Administration, Viking, European Association for, Diabetes, Pfizer, Amgen, Therapeutics Locations: Swiss, Novo, San Antonio, Spain

☆ Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says
▼ + stars: | 2024-07-26 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Weight loss drugs have drawn investor interest and shaken up other sectors in the past year or so. Novo Nordisk and Eli Lilly were two early winners of this trend, as their drugs dominate the weight loss drug market. Yuri Khodjamirian, fund manager at Tema ETFs, said both companies are a "very powerful duopoly." They're a lot more risky than the bigger ones who already have drugs on the market," Khodjamirian said. Tema ETFs offers actively managed exchange-traded funds, with a focus on health care and life sciences.

Persons: Eli Lilly, Yuri Khodjamirian, Goldman Sachs, Khodjamirian, Roche Organizations: Novo Nordisk, Tema, CNBC, Zealand Pharma, Viking Therapeutics, Tema Oncology, Mental Health Locations: Tema

Search resuls for: "Eli Lilly

25 mentions found